胡黄连的化学成分和质量分析及药理作用研究进展
|
摘要
西藏胡黄连为我国传统中药,主要含有环烯醚萜、葫芦素、苯乙醇糖苷和酚苷等化学成分,具有保肝利胆、抗菌消炎、保护受损的神经细胞及凋亡的心肌细胞等多种显著的药理作用。本文通过查阅国内外文献,对胡黄连的化学成分及相关的质量分析方法、药理作用等方面的研究进展进行了较全面的综述,为西藏胡黄连的开发和临床应用提供有价值的参考。
As a traditional Chinese materia medica,Rhizoma picrorhizae has been reported with many kinds of effective components including iridoid glycoside,cucurbitacins,phenylethanoid glycosides and phenolic glycoside,etc. It has the functions of cholagogic,liver-protective,anti-inflammatory,nerve growth enhancement,cardiomyocytes protection and many other significant pharmacological effects. By referring to domestic and foreign literature,this paper reviews the research progress on chemical composition,related quality analytical methods and pharmacological activities of Rhizoma picrorhizae,providing valuable reference for further development and clinical application of Rhizoma picrorhizae.
As a traditional Chinese materia medica,Rhizoma picrorhizae has been reported with many kinds of effective components including iridoid glycoside,cucurbitacins,phenylethanoid glycosides and phenolic glycoside,etc. It has the functions of cholagogic,liver-protective,anti-inflammatory,nerve growth enhancement,cardiomyocytes protection and many other significant pharmacological effects. By referring to domestic and foreign literature,this paper reviews the research progress on chemical composition,related quality analytical methods and pharmacological activities of Rhizoma picrorhizae,providing valuable reference for further development and clinical application of Rhizoma picrorhizae.
引文
[1]国家药典委员会.中华人民共和国药典[S]. 2010年版.一部.北京:中国医药科技出版社,2010:226.
[2]黄开毅,何乐,王大成,等.西藏胡黄连的化学成分[J].中国药学杂志,2008,43(18):1382-1385.
[3]汪豪,吴佳俊,刘戈,等.西藏胡黄连中的环烯醚萜类化学成分[J].中国天然药物,2006,4(1):36-39,86.
[4] KIM IH,UCHIYAMA N,KAWAHARA N,et al. Iridoid glycosides and cucurbitacin glycoside from Neopicrorhiza scrophulariiflora[J]. Phytochemistry,2006,67(24):2691-2696.
[5] HUANG SX,ZHOU Y,NIE QJ,et al. Two new iridoid glucosides from Picrorhiza scrophulariiflora[J]. J Asian Nat Prod Res,2006,8(3):259-263.
[6] KIM IH,KANEKO N,UCHIYAMA N,et al. Two phenylpropanoid glycosides from Neopicrorhiza scrophulariiflora[J]. Chem Pharm Bull,2006,54(2):275-277.
[7]张刘强,韩曼飞,易婧羽,等.西藏胡黄连根茎的化学成分研究[J].中华中医药杂志,2017,32(5):2070-2074.
[8]谢智勇,胡红侠,孔德云,等.西藏胡黄连中两个新化合物的鉴定[J].中国医药工业杂志,2007,38(3):221-226.
[9] LI JX,LI P,TEZUKA Y,et al. Three phenylethanoid glycosides and an iridoid glycoside from Picrorhiza scrophulariiflora[J]. Phytochemistry,1998,48(3):537-542.
[10]胡红侠,杨培明.西藏胡黄连的化学成分研究[J].中国医药工业杂志,2005,36(6):336-339.
[11]王答祺,贺震旦,冯宝树,等.西藏胡黄连的化学成分[J].云南植物研究,1993,15(1):83-88.
[12]黄胜雄.西藏胡黄连的化学成分和提取工艺研究[D].成都:中国科学院成都生物研究所,2004.
[13]朱仝飞,李萍,胡娟娟,等.西藏胡黄连中1个新的裂环环烯醚萜苷类成分[J].中草药,2013,44(23):3260-3263.
[14] ZOU LC,ZHU TF,GAN SC,et al. Two new secoiridoid glycosides from the roots of Picrorhiza scrophulaiiflora[J]. Chin Chem Lett,2008,19(10):1224-1227.
[15] ZHU TF,JIANG K,YAN ZH,et al. A new secoiridoid glycoside from roots of Picrorhiza scrophulariiflora[J]. Chin Herb Med,2013,5(3):237-239.
[16] ZOU LC,ZHU TF,XIANG H,et al. New secoiridoid glycosides from the roots of Picrorhiza scrophulariiflora[J]. Molecules,2008,13(9):2049-2057.
[17] STUPPNER H,WAGNER H. New cucurbitacin glycosides from Picrorhiza kurrooa[J]. Planta Med,1989,55(6):559-563.
[18] ZOU LC,YAN ZH,ZHU TF,et al. Two new phenylethanoidglycosides and a new secoirodoid glycosides from roots of Picrorhiza scrophulariiflora[J]. Chin Chem Lett,2010,21(9):1103-1105.
[19] WANG H,SUN Y,YE WC,et al. Antioxidative phenylethanoid and phenolic glycosides from Picrorhiza scrophulariiflora[J].Chem Pharm Bull,2004,52(5):615-617.
[20]尹立子,欧阳萍,徐雪,等.西藏胡黄连化学成分的分离和鉴定[J].高等学校化学学报,2010,31(1):84-87.
[21] ZOU X,LIAO X,DING LS,et al. Phenyl and phenylethyl glycosides from Picrorhiza scrophulariiflora[J]. J Asian Nat Prod Res,2007,9(3-5):443-448.
[22] ZHU TF,HUANG KY,DENG XM,et al. Three new caffeoyl glycosides from the roots of Picrorhiza scrophulariiflora[J]. Molecules,2008,13(4):729-735.
[23]朱仝飞.蟾酥和西藏胡黄连化学成分的研究[D].沈阳:沈阳药科大学,2008.
[24] WANG H,YE WC,ZHAO SX. Cucurbitacin glycosides and the monoterpene jiofuran from Picrorhiza scrophulariiflora[J]. Biochem Syst Ecol,2004,32(1):87-89
[25]黄开毅,何乐,曲杨,等.西藏胡黄连化学成分的分离与鉴定[J].沈阳药科大学学报,2009,26(2):112-115.
[26] HUANG SX,LIAO X,NIE QJ,et al. Phenyl and phenylethyl glycosides from Picrorhiza scrophulariiflora[J]. Helv Chim Acta,2004,87(3):598-604.
[27]朱仝飞,陈日荣,孙庆文,等.西藏胡黄连化学成分研究[J].中草药,2017,48(2):263-265.
[28]刘志春.西藏胡黄连的化学成分研究进展[J].药学实践杂志,2010,28(5):321-324.
[29] WANG H,YE WC,JIANG RW,et al. Three new cyclopentanoid monoterpenes from Picrorhiza scrophulariiflora[J]. Planta Med,2004,70(4):382-384.
[30] ZENG S,WANG D,CAO Y,et al. Immunopotentiation of caffeoyl glycoside from Picrorhiza scrophulariiflora on activation and cytokines secretion of immunocyte in vitro[J]. Int Immunopharmacol,2008,8(12):1707-1712.
[31]王菁,张朝晖,戴永健,等. HPLC测定胡黄连中胡黄连甙-Ⅱ的含量[J].中国药科大学学报,2000,31(5):368-370.
[32]周菲,倪健. HPLC法测定市售胡黄连中胡黄连苷Ⅰ和胡黄连苷Ⅱ[J].中草药,2010,41(4):658-660.
[33]邬国庆,张小茜.胡黄连质量评价方法的研究[J].中草药,2005,36(12):1886-1888.
[34]杨少华,徐中志,孙蓉,等.云南栽培胡黄连与野生胡黄连有效成份分析[J].云南中医学院学报,2009,32(4):37-39.
[35]张洁,薛润光,刘小莉,等.栽培胡黄连与野生胡黄连的鉴别比较研究[J].中华中医药学刊,2013,31(10):2212-2214.
[36]尹德忠,赵红侠,刘建勋. HPLC同时测定胡黄连中香草酸、阿魏酸和肉桂酸[J].化学与生物工程,2007,24(10):75-76.
[37]于伟.薄层扫描法测定胡黄连中香草酸和桂皮酸的含量[J].黑龙江科技信息,2016(20):91.
[38]王晓静,杨莉,刘德龙,等.三维荧光二阶校正法快速测定胡黄连及体液中香草酸的含量[J].河北师范大学学报(自然科学版),2016,40(5):412-417.
[39]刘时乔,张新鑫,单淇,等.胡黄连中酚类化合物的分离及UPLC-ESI-MS分析[J].天津中医药,2012,29(6):583-587.
[40]王云英,杨天鸣,张艳华,等.西藏胡黄连X射线衍射Fourier图谱鉴定[J].中南民族大学学报(自然科学版),2006,25(4):18-20.
[41]张可佳,孙宁宁,杨雪,等. UPLC结合化学计量学方法的胡黄连指纹图谱研究[J].中草药,2018,49(3):685-693.
[42]孟琳,孙君辉.薄层色谱扫描法测定胡黄连中胡黄连苷Ⅰ含量[J].山东商业职业技术学院学报,2012,12(1):93-94.
[43]石欣,鲍劲松,白雅静. RP-HPLC法测定清热八味胶囊中胡黄连苷Ⅰ的含量[J].中国民族医药杂志,2011,17(3):52-54.
[44]刘美凤.复方胡黄连抗肝炎有效部位的化学研究[D].哈尔滨:黑龙江中医药大学,2001.
[45]李鹏,郑璐,汪斌,等.胡黄连苷-Ⅱ原料药的定性与定量分析[J].中国实验方剂学杂志,2015,21(14):56-58.
[46]张凤仙,魏文鹏. HPLC法测定去滞消积片中胡黄连苷Ⅱ的含量[J].广东医学院学报,2009,27(2):216-218.
[47]韩塔娜.反相HPLC法测定苏斯-12胶囊中胡黄连苷Ⅱ的含量[J].中国民族医药杂志,2009,15(3):64-65.
[48]阎雪莹,刁磊,唐晓飞,等.胡黄连提取物的含量测定及其肝保护作用[J].中医药学报,2009,37(6):13-15.
[49]尚立霞,刘玲玲,王菲,等.高效液相色谱测定清肝颗粒中胡黄连苷Ⅰ和胡黄连苷Ⅱ含量的研究[J].食品与药品,2017,19(3):194-197.
[50]陈惠英,宋粉云.高效液相色谱法测定万应胶囊中胡黄连苷Ⅰ和胡黄连苷Ⅱ的含量[J].中国药房,2006,17(13):1011-1012.
[51]姜海,张妍妍,孟永海,等. HPLC测定清肝疏郁颗粒剂中4种成分的含量[J].中国实验方剂学杂志,2016,22(17):63-66.
[52]严海泓,李宝笙,张雅茜. HPLC法测定胡黄连主根与须根中香草酸与肉桂酸含量[J].天津中医药,2008,25(6):512-514.
[53]刘征辉,叶挺祥,赵洪芝,等.黄连羊肝片质量标准研究[J].中成药,2009,31(8):1315-1318.
[54]莎日娜,何春龙,张宁,等.蒙药胡勒森竹岗-8的定性鉴别研究[J].内蒙古医学院学报,2012,34(5):412-416.
[55]莎日娜,何春龙,王焕芸,等.蒙成药凉血十味散质量标准研究[J].中国药师,2015,18(5):756-758.
[56]钱宇,巴俊杰,田静.蒙药清热八味散的鉴别[J].中医药导报,2015,21(5):45-47.
[57]侯文彬,周福军,单淇,等.胡黄连总苷的高效液相色谱特征图谱研究[J].现代药物与临床,2013,28(5):712-715.
[58]李鹏,薛明,汪斌,等.胡黄连苷-Ⅱ原料药特征图谱研究及有关物质测定[J].药物分析杂志,2015,35(8):1436-1440.
[59]李白雪,冯全生,张传涛,等.胡黄连苷Ⅱ对过氧化氢诱导急性肝细胞损伤中Ⅱ相代谢酶mRNA表达的影响[J].中国中医基础医学杂志,2014,20(7):909-911,938.
[60]李白雪,张传涛,冯全生,等.胡黄连苷Ⅱ对体外H2O2诱导肝细胞(L-02)损伤Keap1_Nrf2(ARE)抗氧化通路mRNA表达的影响[J].中华中医药杂志,2015,30(3):682-685.
[61] GAO H,ZHOU YW. Inhibitory effect of picrosideⅡon hepatocyte apoptosis[J]. Acta Pharmacol Sin,2005,26(6):729-736.
[62]王淑娟,贾志丹,魏怀玲,等.注射用胡黄连总苷对ConA引起小鼠急性免疫性肝损伤的保护作用研究[J].中国药物警戒,2013,10(12):705-708.
[63]刘洁,刘保林,张建强,等.西藏胡黄连保肝利胆作用的研究[J].中国新药杂志,2002,11(6):459-461.
[64]王晓源,韩翠翠,肖洪彬.复方胡黄连对D-半乳糖致急性肝损伤的保护作用及机制[J].长春中医药大学学报,2017,33(6):890-892.
[65] DWIVEDI Y,RASTOGI R,GARG NK,et al. Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats[J]. Pharm Toxicol,1992,71(5):383-387.
[66] DWIVEDI Y,RASTOGI R,MEHROTRA R,et al. Picroliv protects against aflatoxin B1 acute hepatotoxicity in rats[J]. Pharm Res,1993,27(2):189-199.
[67] DWIVEDI Y,RASTOGI R,SHARMA SK,et al. Picroliv affords protection against thioacetamide-induced hepatic damage in rats[J]. Planta Med,1991,57(1):25-28.
[68] DWIVEDI Y,RASTOGI R,CHANDER R,et al. Hepatoprotective activity of picroliv against carbon tetrachloride-induced liver damage in rats[J]. Indian J Med Res,1990,92(92):195-200.
[69] GIRISH C,PRADHAN SC. Hepatoprotective activities of picroliv,curcumin,and ellagic acid compared to silymarin on carbontetrachloride-induced liver toxicity in mice[J]. J Pharm Pharmacother,2012,3(2):149-155.
[70]翁小东,王磊,刘修恒,等.胡黄连苷Ⅱ对大鼠缺血再灌注损伤后炎性反应的影响[J].职业与健康,2016,13(23):3200-3203,3207.
[71]许瑞瑞,张月月,徐岩.胡黄连苷Ⅱ对大鼠肾缺血再灌注损伤的保护作用[J].山东医药,2013,53(36):7-10,112.
[72]张伟,银建军,杨学伟,等.胡黄连对缺血再灌注大鼠脑内NMDAR1 mRNA表达的影响[J].青岛大学医学院学报,2006,42(1):25-26.
[73]李玲,房雷,孙丽,等.胡黄连苷Ⅱ对脑缺血-再灌注损伤后i NOS蛋白及mRNA表达的影响[J].脑与神经疾病杂志,2013,21(3):209-212.
[74]陈红兵,刘一民,赵磊.胡黄连苷Ⅱ对大鼠脑缺血再灌流损伤的保护作用及对AQP4、MMP-9表达的影响[J].中国中医急症,2016,25(1):60-63.
[75]常翠翠,纪晓军,逄芳芳,等.胡黄连苷Ⅱ对大鼠脑缺血损伤后S100β蛋白表达的影响[J].中国康复医学杂志,2014,29(10):901-907.
[76]赵丽,郭云良,李晓丹,等.胡黄连苷Ⅱ对脑缺血损伤后神经元特异性烯醇化酶表达的影响[J].中国药理学通报,2014,30(2):192-199.
[77]于春华,宋梦,曲宪成,等.胡黄连苷Ⅱ治疗大鼠脑缺血损伤的剂量和时间窗研究[J].中国药业,2015,24(20):62-64.
[78]杨永红,张文博,袁鹏英,等.缺氧复氧后肾小管上皮细胞黏附分子1的表达及胡黄连提取物对其的作用[J].中国中西医结合肾病杂志,2013,14(3):239-241.
[79]杨永红,张文博,袁鹏英,等.缺氧复氧后肾小管上皮细胞肿瘤坏死因子α的表达及胡黄连提取物对其的作用[J].中国比较医学杂志,2013,14(10):31-35.
[80]刘洋,刘修恒,王磊,等.胡黄连苷Ⅱ对大鼠肾小管上皮细胞缺氧/复氧损伤的保护作用[J].武汉大学学报(医学版),2017,38(3):381-386.
[81]杨永红,王彩霞,张文博,等.胡黄连提取物对缺氧复氧后肾小管上皮细胞氧化损伤的作用[J].武警医学,2013,24(4):299-301.
[82] SHEN B,ZHAO C,CHEN C,et al. Picroside II protects rat lung and A549 cell against LPS-induced inflammation by the NFkappaB pathway[J]. Inflammation,2017,40(3):752-761.
[83] BA TH,SIMONS JM,KNAANSHANZER S,et al. Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin[J]. Free Radic Biol Med,1990,9(2):127-131.
[84] SUZUKI Y,WANG W,VU TH,et al. Effect of NADPH oxidase inhibition on endothelial cell ELAM-1 mRNA expression[J].Biochem Biophys Res Commun,1992,184(3):1339-1343.
[85] ENGELS F,RENIRIE BF,HART BA,et al. Effects of apocynin,a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism[J]. Febs Lett,1992,305(3):254-256.
[86] JOHNSON DK,SCHILLINGER KJ,KWAIT DM,et al. Inhibition of NADPH oxidase activation in endothelial cells by orthomethoxy-substituted catechols[J]. Endothelium,2002,9(3):191-203.
[87] KUMAR R,GUPTA YK,SINGH S,et al. Anti-inflammatory effect of Picrorhiza kurroa in experimental models of inflammation[J]. Planta Med,2016,82(16):1403-1409.
[88] YANG X,GAO W,WANG B,et al. Picroside II inhibits RANKLmediated osteoclastogenesis by attenuating the NF-kappaB and MAPKs signaling pathway in vitro and prevents bone loss in lipopolysaccharide treatment mice[J]. J Cell Biochem,2017,118(12):4479-4486.
[89]张红艳,翟丽,王婷婷,等.胡黄连苷Ⅱ通过抑制cyto C/caspase-9/caspase-3通路发挥神经保护作用[J].中国药理学通报,2017,33(5):668-674.
[90]黄运林,叶俊宁,刘庭辉.胡黄连苷Ⅱ干预脑缺血再灌注大鼠神经损伤的脑保护作用[J].山西中医,2016,32(6):53-54.
[91]官亚东,翟丽.胡黄连苷Ⅱ对脑缺血损伤后COX-2表达的影响及意义[J].临床医学工程,2016,23(3):288-290.
[92] ZHANG H,ZHAI L,WANG T,et al. Picroside II exerts a neuroprotective effect by inhibiting the mitochondria cytochrome C signal pathway following ischemia reperfusion injury in rats[J]. J Mol Neurosci,2017,61(2):267-278.
[93]周广正,官亚东,张华,等.脑缺血损伤后细胞外信号调节蛋白激酶1/2信号通路及胡黄连苷Ⅱ的干预作用[J].中国现代医学杂志,2015,25(27):22-26.
[94]王婷婷,翟丽,张红艳,等.胡黄连苷Ⅱ对脑缺血损伤大鼠ERK1/2信号通路的影响[J].中国中西医结合杂志,2016,36(4):437-444.
[95]龚苏晓,江纪武.胡黄连中增强神经生长因子作用的化合物[J].国际中医中药杂志,2001,23(6):343-344.
[96] SENTHIL KUMAR SH,ANANDAN R,DEVAKI T,et al. Cardioprotective effect of picrorrhiza Kurroa against isoproterenol-induced myocardial stress in rats[J]. Fitoterapia,2001,72(4):402-405.
[97]胡军,赵渊源,孙靖涵,等.胡黄连苷Ⅱ对乙醇诱导的H9C2心肌细胞损伤的保护作用[J].中国医科大学学报,2014,43(6):523-526,537.
[98]吴楠,李雯娜,吕岩,等.胡黄连苷Ⅱ预处理对大鼠离体心脏缺血再灌注的影响[J].医学研究杂志,2013,42(12):46-49.
[99]张博方,郭鑫,陈静,等.胡黄连苦苷Ⅱ在心肌缺血再灌注损伤中的保护作用及机制[J].临床心血管病杂志,2016,32(9):952-956.
[100] KAPADIA GJ,SHARMA SC,TOKUDA H,et al. Inhibitory effect of iridoids on Epstein-Barr virus activation by a short-term in vitro assay for anti-tumor promoters[J]. Cancer Lett,1996,102(1-2):223-226.
[101] LI T,LIU JW,ZHANG XD,et al. The neuroprotective effect of picroside II from hu-huang-lian against oxidative stress[J].Am J Chin Med,2007,35(4):681-691.
[102] ZAHIRUDDIN S,KHAN W,NEHRA R,et al. Pharmacokinetics and comparative metabolic profiling of iridoid enriched fraction of Picrorhiza kurroa-An ayurvedic herb[J]. J Ethnopharmacol,2017,197(special issue on Ayurveda):157-164.
[103] PATIL V,BANDIVADEKAR A,DEBJANI D. Inhibition of propionibacterium acnes lipase by extracts of Indian medicinal plants[J]. Int J Cosmet Sci,2012,34(3):234-239.
[104] AN N,WANG D,ZHU T,et al. Effects of scrocaffeside A from Picrorhiza scrophulariiflora on immunocyte function in vitro[J].Immunopharmacol Immunotoxicol,2009,31(3):451-458.
[105]曹永国.胡黄连单体Caffeoyl Glycoside免疫活性的体外研究[D].长春:吉林大学,2008.
[106]赵怀舟,王小芸,冯文海,等.胡黄连免煎剂的泻下作用[J].山西中医,2016,32(2):49-51.
[107]苏印泉,马希汉,杨宗英.日本的杜仲研究开发评述[J].西北林学院学报,1996,11(2):94-100.
[108]乔卫,张彦文,吴寿金.天然环烯醚萜类化合物的生物活性[J].现代药物与临床,2001,16(2):65-67.
[109] ANANDAN R,REKHA RD,SARAVANAN N,et al. Protective effects of Picrorhiza kurroa against Hcl/ethanol-induced ulceration in rats[J]. Fitoterapia,1999,70(5):498-501.
[110] ZHOU R,HU YD,LIU LM. Protective effects of apocynin on two-hit injury induced by hemorrhagic shock and lipopolysaccharide[J]. Acta Pharmacol Sin,2002,23(11):1023-1028.
[111]杨崇仁.中古时期我国传统植物药与印度的交流[J].亚太传统医药,2018,14(1):1-9.
[112]陈黄保,梁敏. HPLC法测定消积健儿片中胡黄连苷Ⅱ的含量[J].中国药师,2010,13(10):1476-1477.
[113]毕小平,葛新,张华婷,等.正交实验法筛选胡黄连有效成分的浸出方案[J].山西医科大学学报,2002,33(6):521-522.
[114]王宁,刘汉清,刘志辉,等.胡黄连总苷脂质体中胡黄连苷Ⅱ及包封率的测定[J].中成药,2012,34(4):660-663.
[115]张卫平,孙小成,王静,等.胡黄连苷Ⅰ和胡黄连苷Ⅱ在大鼠体内的药物动力学[J].沈阳药科大学学报,2013,30(9):724-728.
[116]李静姿,田硕涵,赵侠,等.注射用胡黄连总苷在健康人体的药动学[J].中国新药杂志,2014,23(21):2526-2529.
[117]陈丽英.中药胡黄连的相关基础研究[D].上海:上海中医药大学,2017.
[2]黄开毅,何乐,王大成,等.西藏胡黄连的化学成分[J].中国药学杂志,2008,43(18):1382-1385.
[3]汪豪,吴佳俊,刘戈,等.西藏胡黄连中的环烯醚萜类化学成分[J].中国天然药物,2006,4(1):36-39,86.
[4] KIM IH,UCHIYAMA N,KAWAHARA N,et al. Iridoid glycosides and cucurbitacin glycoside from Neopicrorhiza scrophulariiflora[J]. Phytochemistry,2006,67(24):2691-2696.
[5] HUANG SX,ZHOU Y,NIE QJ,et al. Two new iridoid glucosides from Picrorhiza scrophulariiflora[J]. J Asian Nat Prod Res,2006,8(3):259-263.
[6] KIM IH,KANEKO N,UCHIYAMA N,et al. Two phenylpropanoid glycosides from Neopicrorhiza scrophulariiflora[J]. Chem Pharm Bull,2006,54(2):275-277.
[7]张刘强,韩曼飞,易婧羽,等.西藏胡黄连根茎的化学成分研究[J].中华中医药杂志,2017,32(5):2070-2074.
[8]谢智勇,胡红侠,孔德云,等.西藏胡黄连中两个新化合物的鉴定[J].中国医药工业杂志,2007,38(3):221-226.
[9] LI JX,LI P,TEZUKA Y,et al. Three phenylethanoid glycosides and an iridoid glycoside from Picrorhiza scrophulariiflora[J]. Phytochemistry,1998,48(3):537-542.
[10]胡红侠,杨培明.西藏胡黄连的化学成分研究[J].中国医药工业杂志,2005,36(6):336-339.
[11]王答祺,贺震旦,冯宝树,等.西藏胡黄连的化学成分[J].云南植物研究,1993,15(1):83-88.
[12]黄胜雄.西藏胡黄连的化学成分和提取工艺研究[D].成都:中国科学院成都生物研究所,2004.
[13]朱仝飞,李萍,胡娟娟,等.西藏胡黄连中1个新的裂环环烯醚萜苷类成分[J].中草药,2013,44(23):3260-3263.
[14] ZOU LC,ZHU TF,GAN SC,et al. Two new secoiridoid glycosides from the roots of Picrorhiza scrophulaiiflora[J]. Chin Chem Lett,2008,19(10):1224-1227.
[15] ZHU TF,JIANG K,YAN ZH,et al. A new secoiridoid glycoside from roots of Picrorhiza scrophulariiflora[J]. Chin Herb Med,2013,5(3):237-239.
[16] ZOU LC,ZHU TF,XIANG H,et al. New secoiridoid glycosides from the roots of Picrorhiza scrophulariiflora[J]. Molecules,2008,13(9):2049-2057.
[17] STUPPNER H,WAGNER H. New cucurbitacin glycosides from Picrorhiza kurrooa[J]. Planta Med,1989,55(6):559-563.
[18] ZOU LC,YAN ZH,ZHU TF,et al. Two new phenylethanoidglycosides and a new secoirodoid glycosides from roots of Picrorhiza scrophulariiflora[J]. Chin Chem Lett,2010,21(9):1103-1105.
[19] WANG H,SUN Y,YE WC,et al. Antioxidative phenylethanoid and phenolic glycosides from Picrorhiza scrophulariiflora[J].Chem Pharm Bull,2004,52(5):615-617.
[20]尹立子,欧阳萍,徐雪,等.西藏胡黄连化学成分的分离和鉴定[J].高等学校化学学报,2010,31(1):84-87.
[21] ZOU X,LIAO X,DING LS,et al. Phenyl and phenylethyl glycosides from Picrorhiza scrophulariiflora[J]. J Asian Nat Prod Res,2007,9(3-5):443-448.
[22] ZHU TF,HUANG KY,DENG XM,et al. Three new caffeoyl glycosides from the roots of Picrorhiza scrophulariiflora[J]. Molecules,2008,13(4):729-735.
[23]朱仝飞.蟾酥和西藏胡黄连化学成分的研究[D].沈阳:沈阳药科大学,2008.
[24] WANG H,YE WC,ZHAO SX. Cucurbitacin glycosides and the monoterpene jiofuran from Picrorhiza scrophulariiflora[J]. Biochem Syst Ecol,2004,32(1):87-89
[25]黄开毅,何乐,曲杨,等.西藏胡黄连化学成分的分离与鉴定[J].沈阳药科大学学报,2009,26(2):112-115.
[26] HUANG SX,LIAO X,NIE QJ,et al. Phenyl and phenylethyl glycosides from Picrorhiza scrophulariiflora[J]. Helv Chim Acta,2004,87(3):598-604.
[27]朱仝飞,陈日荣,孙庆文,等.西藏胡黄连化学成分研究[J].中草药,2017,48(2):263-265.
[28]刘志春.西藏胡黄连的化学成分研究进展[J].药学实践杂志,2010,28(5):321-324.
[29] WANG H,YE WC,JIANG RW,et al. Three new cyclopentanoid monoterpenes from Picrorhiza scrophulariiflora[J]. Planta Med,2004,70(4):382-384.
[30] ZENG S,WANG D,CAO Y,et al. Immunopotentiation of caffeoyl glycoside from Picrorhiza scrophulariiflora on activation and cytokines secretion of immunocyte in vitro[J]. Int Immunopharmacol,2008,8(12):1707-1712.
[31]王菁,张朝晖,戴永健,等. HPLC测定胡黄连中胡黄连甙-Ⅱ的含量[J].中国药科大学学报,2000,31(5):368-370.
[32]周菲,倪健. HPLC法测定市售胡黄连中胡黄连苷Ⅰ和胡黄连苷Ⅱ[J].中草药,2010,41(4):658-660.
[33]邬国庆,张小茜.胡黄连质量评价方法的研究[J].中草药,2005,36(12):1886-1888.
[34]杨少华,徐中志,孙蓉,等.云南栽培胡黄连与野生胡黄连有效成份分析[J].云南中医学院学报,2009,32(4):37-39.
[35]张洁,薛润光,刘小莉,等.栽培胡黄连与野生胡黄连的鉴别比较研究[J].中华中医药学刊,2013,31(10):2212-2214.
[36]尹德忠,赵红侠,刘建勋. HPLC同时测定胡黄连中香草酸、阿魏酸和肉桂酸[J].化学与生物工程,2007,24(10):75-76.
[37]于伟.薄层扫描法测定胡黄连中香草酸和桂皮酸的含量[J].黑龙江科技信息,2016(20):91.
[38]王晓静,杨莉,刘德龙,等.三维荧光二阶校正法快速测定胡黄连及体液中香草酸的含量[J].河北师范大学学报(自然科学版),2016,40(5):412-417.
[39]刘时乔,张新鑫,单淇,等.胡黄连中酚类化合物的分离及UPLC-ESI-MS分析[J].天津中医药,2012,29(6):583-587.
[40]王云英,杨天鸣,张艳华,等.西藏胡黄连X射线衍射Fourier图谱鉴定[J].中南民族大学学报(自然科学版),2006,25(4):18-20.
[41]张可佳,孙宁宁,杨雪,等. UPLC结合化学计量学方法的胡黄连指纹图谱研究[J].中草药,2018,49(3):685-693.
[42]孟琳,孙君辉.薄层色谱扫描法测定胡黄连中胡黄连苷Ⅰ含量[J].山东商业职业技术学院学报,2012,12(1):93-94.
[43]石欣,鲍劲松,白雅静. RP-HPLC法测定清热八味胶囊中胡黄连苷Ⅰ的含量[J].中国民族医药杂志,2011,17(3):52-54.
[44]刘美凤.复方胡黄连抗肝炎有效部位的化学研究[D].哈尔滨:黑龙江中医药大学,2001.
[45]李鹏,郑璐,汪斌,等.胡黄连苷-Ⅱ原料药的定性与定量分析[J].中国实验方剂学杂志,2015,21(14):56-58.
[46]张凤仙,魏文鹏. HPLC法测定去滞消积片中胡黄连苷Ⅱ的含量[J].广东医学院学报,2009,27(2):216-218.
[47]韩塔娜.反相HPLC法测定苏斯-12胶囊中胡黄连苷Ⅱ的含量[J].中国民族医药杂志,2009,15(3):64-65.
[48]阎雪莹,刁磊,唐晓飞,等.胡黄连提取物的含量测定及其肝保护作用[J].中医药学报,2009,37(6):13-15.
[49]尚立霞,刘玲玲,王菲,等.高效液相色谱测定清肝颗粒中胡黄连苷Ⅰ和胡黄连苷Ⅱ含量的研究[J].食品与药品,2017,19(3):194-197.
[50]陈惠英,宋粉云.高效液相色谱法测定万应胶囊中胡黄连苷Ⅰ和胡黄连苷Ⅱ的含量[J].中国药房,2006,17(13):1011-1012.
[51]姜海,张妍妍,孟永海,等. HPLC测定清肝疏郁颗粒剂中4种成分的含量[J].中国实验方剂学杂志,2016,22(17):63-66.
[52]严海泓,李宝笙,张雅茜. HPLC法测定胡黄连主根与须根中香草酸与肉桂酸含量[J].天津中医药,2008,25(6):512-514.
[53]刘征辉,叶挺祥,赵洪芝,等.黄连羊肝片质量标准研究[J].中成药,2009,31(8):1315-1318.
[54]莎日娜,何春龙,张宁,等.蒙药胡勒森竹岗-8的定性鉴别研究[J].内蒙古医学院学报,2012,34(5):412-416.
[55]莎日娜,何春龙,王焕芸,等.蒙成药凉血十味散质量标准研究[J].中国药师,2015,18(5):756-758.
[56]钱宇,巴俊杰,田静.蒙药清热八味散的鉴别[J].中医药导报,2015,21(5):45-47.
[57]侯文彬,周福军,单淇,等.胡黄连总苷的高效液相色谱特征图谱研究[J].现代药物与临床,2013,28(5):712-715.
[58]李鹏,薛明,汪斌,等.胡黄连苷-Ⅱ原料药特征图谱研究及有关物质测定[J].药物分析杂志,2015,35(8):1436-1440.
[59]李白雪,冯全生,张传涛,等.胡黄连苷Ⅱ对过氧化氢诱导急性肝细胞损伤中Ⅱ相代谢酶mRNA表达的影响[J].中国中医基础医学杂志,2014,20(7):909-911,938.
[60]李白雪,张传涛,冯全生,等.胡黄连苷Ⅱ对体外H2O2诱导肝细胞(L-02)损伤Keap1_Nrf2(ARE)抗氧化通路mRNA表达的影响[J].中华中医药杂志,2015,30(3):682-685.
[61] GAO H,ZHOU YW. Inhibitory effect of picrosideⅡon hepatocyte apoptosis[J]. Acta Pharmacol Sin,2005,26(6):729-736.
[62]王淑娟,贾志丹,魏怀玲,等.注射用胡黄连总苷对ConA引起小鼠急性免疫性肝损伤的保护作用研究[J].中国药物警戒,2013,10(12):705-708.
[63]刘洁,刘保林,张建强,等.西藏胡黄连保肝利胆作用的研究[J].中国新药杂志,2002,11(6):459-461.
[64]王晓源,韩翠翠,肖洪彬.复方胡黄连对D-半乳糖致急性肝损伤的保护作用及机制[J].长春中医药大学学报,2017,33(6):890-892.
[65] DWIVEDI Y,RASTOGI R,GARG NK,et al. Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats[J]. Pharm Toxicol,1992,71(5):383-387.
[66] DWIVEDI Y,RASTOGI R,MEHROTRA R,et al. Picroliv protects against aflatoxin B1 acute hepatotoxicity in rats[J]. Pharm Res,1993,27(2):189-199.
[67] DWIVEDI Y,RASTOGI R,SHARMA SK,et al. Picroliv affords protection against thioacetamide-induced hepatic damage in rats[J]. Planta Med,1991,57(1):25-28.
[68] DWIVEDI Y,RASTOGI R,CHANDER R,et al. Hepatoprotective activity of picroliv against carbon tetrachloride-induced liver damage in rats[J]. Indian J Med Res,1990,92(92):195-200.
[69] GIRISH C,PRADHAN SC. Hepatoprotective activities of picroliv,curcumin,and ellagic acid compared to silymarin on carbontetrachloride-induced liver toxicity in mice[J]. J Pharm Pharmacother,2012,3(2):149-155.
[70]翁小东,王磊,刘修恒,等.胡黄连苷Ⅱ对大鼠缺血再灌注损伤后炎性反应的影响[J].职业与健康,2016,13(23):3200-3203,3207.
[71]许瑞瑞,张月月,徐岩.胡黄连苷Ⅱ对大鼠肾缺血再灌注损伤的保护作用[J].山东医药,2013,53(36):7-10,112.
[72]张伟,银建军,杨学伟,等.胡黄连对缺血再灌注大鼠脑内NMDAR1 mRNA表达的影响[J].青岛大学医学院学报,2006,42(1):25-26.
[73]李玲,房雷,孙丽,等.胡黄连苷Ⅱ对脑缺血-再灌注损伤后i NOS蛋白及mRNA表达的影响[J].脑与神经疾病杂志,2013,21(3):209-212.
[74]陈红兵,刘一民,赵磊.胡黄连苷Ⅱ对大鼠脑缺血再灌流损伤的保护作用及对AQP4、MMP-9表达的影响[J].中国中医急症,2016,25(1):60-63.
[75]常翠翠,纪晓军,逄芳芳,等.胡黄连苷Ⅱ对大鼠脑缺血损伤后S100β蛋白表达的影响[J].中国康复医学杂志,2014,29(10):901-907.
[76]赵丽,郭云良,李晓丹,等.胡黄连苷Ⅱ对脑缺血损伤后神经元特异性烯醇化酶表达的影响[J].中国药理学通报,2014,30(2):192-199.
[77]于春华,宋梦,曲宪成,等.胡黄连苷Ⅱ治疗大鼠脑缺血损伤的剂量和时间窗研究[J].中国药业,2015,24(20):62-64.
[78]杨永红,张文博,袁鹏英,等.缺氧复氧后肾小管上皮细胞黏附分子1的表达及胡黄连提取物对其的作用[J].中国中西医结合肾病杂志,2013,14(3):239-241.
[79]杨永红,张文博,袁鹏英,等.缺氧复氧后肾小管上皮细胞肿瘤坏死因子α的表达及胡黄连提取物对其的作用[J].中国比较医学杂志,2013,14(10):31-35.
[80]刘洋,刘修恒,王磊,等.胡黄连苷Ⅱ对大鼠肾小管上皮细胞缺氧/复氧损伤的保护作用[J].武汉大学学报(医学版),2017,38(3):381-386.
[81]杨永红,王彩霞,张文博,等.胡黄连提取物对缺氧复氧后肾小管上皮细胞氧化损伤的作用[J].武警医学,2013,24(4):299-301.
[82] SHEN B,ZHAO C,CHEN C,et al. Picroside II protects rat lung and A549 cell against LPS-induced inflammation by the NFkappaB pathway[J]. Inflammation,2017,40(3):752-761.
[83] BA TH,SIMONS JM,KNAANSHANZER S,et al. Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin[J]. Free Radic Biol Med,1990,9(2):127-131.
[84] SUZUKI Y,WANG W,VU TH,et al. Effect of NADPH oxidase inhibition on endothelial cell ELAM-1 mRNA expression[J].Biochem Biophys Res Commun,1992,184(3):1339-1343.
[85] ENGELS F,RENIRIE BF,HART BA,et al. Effects of apocynin,a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism[J]. Febs Lett,1992,305(3):254-256.
[86] JOHNSON DK,SCHILLINGER KJ,KWAIT DM,et al. Inhibition of NADPH oxidase activation in endothelial cells by orthomethoxy-substituted catechols[J]. Endothelium,2002,9(3):191-203.
[87] KUMAR R,GUPTA YK,SINGH S,et al. Anti-inflammatory effect of Picrorhiza kurroa in experimental models of inflammation[J]. Planta Med,2016,82(16):1403-1409.
[88] YANG X,GAO W,WANG B,et al. Picroside II inhibits RANKLmediated osteoclastogenesis by attenuating the NF-kappaB and MAPKs signaling pathway in vitro and prevents bone loss in lipopolysaccharide treatment mice[J]. J Cell Biochem,2017,118(12):4479-4486.
[89]张红艳,翟丽,王婷婷,等.胡黄连苷Ⅱ通过抑制cyto C/caspase-9/caspase-3通路发挥神经保护作用[J].中国药理学通报,2017,33(5):668-674.
[90]黄运林,叶俊宁,刘庭辉.胡黄连苷Ⅱ干预脑缺血再灌注大鼠神经损伤的脑保护作用[J].山西中医,2016,32(6):53-54.
[91]官亚东,翟丽.胡黄连苷Ⅱ对脑缺血损伤后COX-2表达的影响及意义[J].临床医学工程,2016,23(3):288-290.
[92] ZHANG H,ZHAI L,WANG T,et al. Picroside II exerts a neuroprotective effect by inhibiting the mitochondria cytochrome C signal pathway following ischemia reperfusion injury in rats[J]. J Mol Neurosci,2017,61(2):267-278.
[93]周广正,官亚东,张华,等.脑缺血损伤后细胞外信号调节蛋白激酶1/2信号通路及胡黄连苷Ⅱ的干预作用[J].中国现代医学杂志,2015,25(27):22-26.
[94]王婷婷,翟丽,张红艳,等.胡黄连苷Ⅱ对脑缺血损伤大鼠ERK1/2信号通路的影响[J].中国中西医结合杂志,2016,36(4):437-444.
[95]龚苏晓,江纪武.胡黄连中增强神经生长因子作用的化合物[J].国际中医中药杂志,2001,23(6):343-344.
[96] SENTHIL KUMAR SH,ANANDAN R,DEVAKI T,et al. Cardioprotective effect of picrorrhiza Kurroa against isoproterenol-induced myocardial stress in rats[J]. Fitoterapia,2001,72(4):402-405.
[97]胡军,赵渊源,孙靖涵,等.胡黄连苷Ⅱ对乙醇诱导的H9C2心肌细胞损伤的保护作用[J].中国医科大学学报,2014,43(6):523-526,537.
[98]吴楠,李雯娜,吕岩,等.胡黄连苷Ⅱ预处理对大鼠离体心脏缺血再灌注的影响[J].医学研究杂志,2013,42(12):46-49.
[99]张博方,郭鑫,陈静,等.胡黄连苦苷Ⅱ在心肌缺血再灌注损伤中的保护作用及机制[J].临床心血管病杂志,2016,32(9):952-956.
[100] KAPADIA GJ,SHARMA SC,TOKUDA H,et al. Inhibitory effect of iridoids on Epstein-Barr virus activation by a short-term in vitro assay for anti-tumor promoters[J]. Cancer Lett,1996,102(1-2):223-226.
[101] LI T,LIU JW,ZHANG XD,et al. The neuroprotective effect of picroside II from hu-huang-lian against oxidative stress[J].Am J Chin Med,2007,35(4):681-691.
[102] ZAHIRUDDIN S,KHAN W,NEHRA R,et al. Pharmacokinetics and comparative metabolic profiling of iridoid enriched fraction of Picrorhiza kurroa-An ayurvedic herb[J]. J Ethnopharmacol,2017,197(special issue on Ayurveda):157-164.
[103] PATIL V,BANDIVADEKAR A,DEBJANI D. Inhibition of propionibacterium acnes lipase by extracts of Indian medicinal plants[J]. Int J Cosmet Sci,2012,34(3):234-239.
[104] AN N,WANG D,ZHU T,et al. Effects of scrocaffeside A from Picrorhiza scrophulariiflora on immunocyte function in vitro[J].Immunopharmacol Immunotoxicol,2009,31(3):451-458.
[105]曹永国.胡黄连单体Caffeoyl Glycoside免疫活性的体外研究[D].长春:吉林大学,2008.
[106]赵怀舟,王小芸,冯文海,等.胡黄连免煎剂的泻下作用[J].山西中医,2016,32(2):49-51.
[107]苏印泉,马希汉,杨宗英.日本的杜仲研究开发评述[J].西北林学院学报,1996,11(2):94-100.
[108]乔卫,张彦文,吴寿金.天然环烯醚萜类化合物的生物活性[J].现代药物与临床,2001,16(2):65-67.
[109] ANANDAN R,REKHA RD,SARAVANAN N,et al. Protective effects of Picrorhiza kurroa against Hcl/ethanol-induced ulceration in rats[J]. Fitoterapia,1999,70(5):498-501.
[110] ZHOU R,HU YD,LIU LM. Protective effects of apocynin on two-hit injury induced by hemorrhagic shock and lipopolysaccharide[J]. Acta Pharmacol Sin,2002,23(11):1023-1028.
[111]杨崇仁.中古时期我国传统植物药与印度的交流[J].亚太传统医药,2018,14(1):1-9.
[112]陈黄保,梁敏. HPLC法测定消积健儿片中胡黄连苷Ⅱ的含量[J].中国药师,2010,13(10):1476-1477.
[113]毕小平,葛新,张华婷,等.正交实验法筛选胡黄连有效成分的浸出方案[J].山西医科大学学报,2002,33(6):521-522.
[114]王宁,刘汉清,刘志辉,等.胡黄连总苷脂质体中胡黄连苷Ⅱ及包封率的测定[J].中成药,2012,34(4):660-663.
[115]张卫平,孙小成,王静,等.胡黄连苷Ⅰ和胡黄连苷Ⅱ在大鼠体内的药物动力学[J].沈阳药科大学学报,2013,30(9):724-728.
[116]李静姿,田硕涵,赵侠,等.注射用胡黄连总苷在健康人体的药动学[J].中国新药杂志,2014,23(21):2526-2529.
[117]陈丽英.中药胡黄连的相关基础研究[D].上海:上海中医药大学,2017.